Appeals Court Strikes Down EPA’s Denial of SREs
*Please Note – Bob Lane was out of the office today and will return on Tuesday, November 28, 2023.
On November 22, a U.S. appeals court struck down a decision...
The cannabis industry is not monolithic, with distinct interests on either side of the THC regulatory divide. Marijuana stakeholders resent the regulatory advantage that hemp operators have. Intoxicants like delta-8 THC are far more profitable than highly regulated and specially taxed flower or delta-9 THC type extracts. Some states are regulating and taxing hemp-derived cannabinoids, but others are taking a laissez-faire approach to this product category.
In active state cannabis markets like California, Oregon, and Colorado, delta-8 THC faced far stronger headwinds than states with no legal marijuana markets. Even smokable hemp saw early aggressive pushback by cannabis lobby in California, a product with no purported intoxicating benefits.